Presented by: Daniel Lim, M.D., Ph.D., Assistant Professor of Neurological Surgery, University of California, San Francisco. Accurexa is developing a medical stereotactic device, which the Company believes has the potential to significantly improve the delivery of stem cells into the human brain and enhance the efficacy of a wide range of stem cell therapeutics.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.